Colectomy is a risk factor for venous thromboembolism in ulcerative colitis

AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World journal of gastroenterology : WJG 2015-01, Vol.21 (4), p.1251-1260
Hauptverfasser: Kaplan, Gilaad G, Lim, Allen, Seow, Cynthia H, Moran, Gordon W, Ghosh, Subrata, Leung, Yvette, Debruyn, Jennifer, Nguyen, Geoffrey C, Hubbard, James, Panaccione, Remo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1260
container_issue 4
container_start_page 1251
container_title World journal of gastroenterology : WJG
container_volume 21
creator Kaplan, Gilaad G
Lim, Allen
Seow, Cynthia H
Moran, Gordon W
Ghosh, Subrata
Leung, Yvette
Debruyn, Jennifer
Nguyen, Geoffrey C
Hubbard, James
Panaccione, Remo
description AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by:(1) responsive to inpatient medical therapy(n = 382);(2) medically refractory requiring emergent colectomy(n = 309); and(3) elective colectomy(n = 329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course(i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications(i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios(OR) with 95%CI.RESULTS: The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparinprophylaxis. In contrast, VTE was higher among patients who underwent an emergent(8.7%) and elective(4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal(45.8%) followed by lower extremity(19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective(adjusted OR = 3.69; 95%CI: 1.30-10.44) and emergent colectomy(adjusted OR = 5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time(adjusted OR = 1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE. CONCLUSION: VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy.
doi_str_mv 10.3748/wjg.v21.i4.1251
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4306170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849534852485053</cqvip_id><sourcerecordid>1652430813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-82ca02c0b353e7e8e883a6df63a516e7365e7fa7ae6027e3c868179e341a80103</originalsourceid><addsrcrecordid>eNpVkU1PGzEQhq2qqKTQc2-Vj71ssD3-2kslFEFbFakXOFuOmU0Mu2uwN6n49zhKiKilkaXxM--M5yXkK2dzMNJe_HtYzbeCz6Occ6H4BzITgreNsJJ9JDPOmGlaEOaUfC7lgTEBoMQnciqUhsq1M_JnkXoMUxpeaCzU0xzLI-18zWTa1djimDaFTuuchmXCGn0sA40j3fQBs5_iFmmoySmWc3LS-b7gl8N9Ru6ur24Xv5qbvz9_Ly5vmqAYTI0VwTMR2BIUoEGL1oLX950Gr7hGA1qh6bzxqJkwCMFqy02LILm3jDM4Iz_2uk-b5YD3Accp-9495Tj4_OKSj-7_lzGu3SptnQSmudkJfD8I5PS8wTK5IZaAfe9HrL91XCtRWcuhohd7NORUSsbu2IYzt7PAVQtctcBF6XYW1Ipv76c78m87rwAcJNdpXD3HcXVkWmZ3p1VMWtkqkLYOYhVTAK_D_ZN8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652430813</pqid></control><display><type>article</type><title>Colectomy is a risk factor for venous thromboembolism in ulcerative colitis</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kaplan, Gilaad G ; Lim, Allen ; Seow, Cynthia H ; Moran, Gordon W ; Ghosh, Subrata ; Leung, Yvette ; Debruyn, Jennifer ; Nguyen, Geoffrey C ; Hubbard, James ; Panaccione, Remo</creator><creatorcontrib>Kaplan, Gilaad G ; Lim, Allen ; Seow, Cynthia H ; Moran, Gordon W ; Ghosh, Subrata ; Leung, Yvette ; Debruyn, Jennifer ; Nguyen, Geoffrey C ; Hubbard, James ; Panaccione, Remo</creatorcontrib><description>AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by:(1) responsive to inpatient medical therapy(n = 382);(2) medically refractory requiring emergent colectomy(n = 309); and(3) elective colectomy(n = 329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course(i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications(i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios(OR) with 95%CI.RESULTS: The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparinprophylaxis. In contrast, VTE was higher among patients who underwent an emergent(8.7%) and elective(4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal(45.8%) followed by lower extremity(19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective(adjusted OR = 3.69; 95%CI: 1.30-10.44) and emergent colectomy(adjusted OR = 5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time(adjusted OR = 1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE. CONCLUSION: VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v21.i4.1251</identifier><identifier>PMID: 25632199</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Adolescent ; Adult ; Anticoagulants - therapeutic use ; bowel ; Colectomy - adverse effects ; Colitis, Ulcerative - complications ; Colitis, Ulcerative - diagnosis ; Colitis, Ulcerative - drug therapy ; Colitis, Ulcerative - surgery ; colitis;Dee ; diseases;Ulcerative ; Elective Surgical Procedures ; Emergencies ; Female ; Gastrointestinal Agents - adverse effects ; Gastrointestinal Agents - therapeutic use ; Heparin - therapeutic use ; Humans ; Inflammatory ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Observational Study ; Odds Ratio ; Risk Factors ; Time Factors ; Treatment Outcome ; Venous Thromboembolism - etiology ; Venous Thromboembolism - prevention &amp; control ; Young Adult</subject><ispartof>World journal of gastroenterology : WJG, 2015-01, Vol.21 (4), p.1251-1260</ispartof><rights>The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-82ca02c0b353e7e8e883a6df63a516e7365e7fa7ae6027e3c868179e341a80103</citedby><cites>FETCH-LOGICAL-c503t-82ca02c0b353e7e8e883a6df63a516e7365e7fa7ae6027e3c868179e341a80103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306170/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306170/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25632199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaplan, Gilaad G</creatorcontrib><creatorcontrib>Lim, Allen</creatorcontrib><creatorcontrib>Seow, Cynthia H</creatorcontrib><creatorcontrib>Moran, Gordon W</creatorcontrib><creatorcontrib>Ghosh, Subrata</creatorcontrib><creatorcontrib>Leung, Yvette</creatorcontrib><creatorcontrib>Debruyn, Jennifer</creatorcontrib><creatorcontrib>Nguyen, Geoffrey C</creatorcontrib><creatorcontrib>Hubbard, James</creatorcontrib><creatorcontrib>Panaccione, Remo</creatorcontrib><title>Colectomy is a risk factor for venous thromboembolism in ulcerative colitis</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by:(1) responsive to inpatient medical therapy(n = 382);(2) medically refractory requiring emergent colectomy(n = 309); and(3) elective colectomy(n = 329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course(i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications(i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios(OR) with 95%CI.RESULTS: The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparinprophylaxis. In contrast, VTE was higher among patients who underwent an emergent(8.7%) and elective(4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal(45.8%) followed by lower extremity(19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective(adjusted OR = 3.69; 95%CI: 1.30-10.44) and emergent colectomy(adjusted OR = 5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time(adjusted OR = 1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE. CONCLUSION: VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anticoagulants - therapeutic use</subject><subject>bowel</subject><subject>Colectomy - adverse effects</subject><subject>Colitis, Ulcerative - complications</subject><subject>Colitis, Ulcerative - diagnosis</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Colitis, Ulcerative - surgery</subject><subject>colitis;Dee</subject><subject>diseases;Ulcerative</subject><subject>Elective Surgical Procedures</subject><subject>Emergencies</subject><subject>Female</subject><subject>Gastrointestinal Agents - adverse effects</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Heparin - therapeutic use</subject><subject>Humans</subject><subject>Inflammatory</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Observational Study</subject><subject>Odds Ratio</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Venous Thromboembolism - etiology</subject><subject>Venous Thromboembolism - prevention &amp; control</subject><subject>Young Adult</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1PGzEQhq2qqKTQc2-Vj71ssD3-2kslFEFbFakXOFuOmU0Mu2uwN6n49zhKiKilkaXxM--M5yXkK2dzMNJe_HtYzbeCz6Occ6H4BzITgreNsJJ9JDPOmGlaEOaUfC7lgTEBoMQnciqUhsq1M_JnkXoMUxpeaCzU0xzLI-18zWTa1djimDaFTuuchmXCGn0sA40j3fQBs5_iFmmoySmWc3LS-b7gl8N9Ru6ur24Xv5qbvz9_Ly5vmqAYTI0VwTMR2BIUoEGL1oLX950Gr7hGA1qh6bzxqJkwCMFqy02LILm3jDM4Iz_2uk-b5YD3Accp-9495Tj4_OKSj-7_lzGu3SptnQSmudkJfD8I5PS8wTK5IZaAfe9HrL91XCtRWcuhohd7NORUSsbu2IYzt7PAVQtctcBF6XYW1Ipv76c78m87rwAcJNdpXD3HcXVkWmZ3p1VMWtkqkLYOYhVTAK_D_ZN8</recordid><startdate>20150128</startdate><enddate>20150128</enddate><creator>Kaplan, Gilaad G</creator><creator>Lim, Allen</creator><creator>Seow, Cynthia H</creator><creator>Moran, Gordon W</creator><creator>Ghosh, Subrata</creator><creator>Leung, Yvette</creator><creator>Debruyn, Jennifer</creator><creator>Nguyen, Geoffrey C</creator><creator>Hubbard, James</creator><creator>Panaccione, Remo</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150128</creationdate><title>Colectomy is a risk factor for venous thromboembolism in ulcerative colitis</title><author>Kaplan, Gilaad G ; Lim, Allen ; Seow, Cynthia H ; Moran, Gordon W ; Ghosh, Subrata ; Leung, Yvette ; Debruyn, Jennifer ; Nguyen, Geoffrey C ; Hubbard, James ; Panaccione, Remo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-82ca02c0b353e7e8e883a6df63a516e7365e7fa7ae6027e3c868179e341a80103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anticoagulants - therapeutic use</topic><topic>bowel</topic><topic>Colectomy - adverse effects</topic><topic>Colitis, Ulcerative - complications</topic><topic>Colitis, Ulcerative - diagnosis</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Colitis, Ulcerative - surgery</topic><topic>colitis;Dee</topic><topic>diseases;Ulcerative</topic><topic>Elective Surgical Procedures</topic><topic>Emergencies</topic><topic>Female</topic><topic>Gastrointestinal Agents - adverse effects</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Heparin - therapeutic use</topic><topic>Humans</topic><topic>Inflammatory</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Observational Study</topic><topic>Odds Ratio</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Venous Thromboembolism - etiology</topic><topic>Venous Thromboembolism - prevention &amp; control</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Kaplan, Gilaad G</creatorcontrib><creatorcontrib>Lim, Allen</creatorcontrib><creatorcontrib>Seow, Cynthia H</creatorcontrib><creatorcontrib>Moran, Gordon W</creatorcontrib><creatorcontrib>Ghosh, Subrata</creatorcontrib><creatorcontrib>Leung, Yvette</creatorcontrib><creatorcontrib>Debruyn, Jennifer</creatorcontrib><creatorcontrib>Nguyen, Geoffrey C</creatorcontrib><creatorcontrib>Hubbard, James</creatorcontrib><creatorcontrib>Panaccione, Remo</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaplan, Gilaad G</au><au>Lim, Allen</au><au>Seow, Cynthia H</au><au>Moran, Gordon W</au><au>Ghosh, Subrata</au><au>Leung, Yvette</au><au>Debruyn, Jennifer</au><au>Nguyen, Geoffrey C</au><au>Hubbard, James</au><au>Panaccione, Remo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colectomy is a risk factor for venous thromboembolism in ulcerative colitis</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2015-01-28</date><risdate>2015</risdate><volume>21</volume><issue>4</issue><spage>1251</spage><epage>1260</epage><pages>1251-1260</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by:(1) responsive to inpatient medical therapy(n = 382);(2) medically refractory requiring emergent colectomy(n = 309); and(3) elective colectomy(n = 329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course(i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications(i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios(OR) with 95%CI.RESULTS: The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparinprophylaxis. In contrast, VTE was higher among patients who underwent an emergent(8.7%) and elective(4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal(45.8%) followed by lower extremity(19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective(adjusted OR = 3.69; 95%CI: 1.30-10.44) and emergent colectomy(adjusted OR = 5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time(adjusted OR = 1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE. CONCLUSION: VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>25632199</pmid><doi>10.3748/wjg.v21.i4.1251</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2015-01, Vol.21 (4), p.1251-1260
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4306170
source MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adolescent
Adult
Anticoagulants - therapeutic use
bowel
Colectomy - adverse effects
Colitis, Ulcerative - complications
Colitis, Ulcerative - diagnosis
Colitis, Ulcerative - drug therapy
Colitis, Ulcerative - surgery
colitis
Dee
diseases
Ulcerative
Elective Surgical Procedures
Emergencies
Female
Gastrointestinal Agents - adverse effects
Gastrointestinal Agents - therapeutic use
Heparin - therapeutic use
Humans
Inflammatory
Logistic Models
Male
Middle Aged
Multivariate Analysis
Observational Study
Odds Ratio
Risk Factors
Time Factors
Treatment Outcome
Venous Thromboembolism - etiology
Venous Thromboembolism - prevention & control
Young Adult
title Colectomy is a risk factor for venous thromboembolism in ulcerative colitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A13%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colectomy%20is%20a%20risk%20factor%20for%20venous%20thromboembolism%20in%20ulcerative%20colitis&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Kaplan,%20Gilaad%20G&rft.date=2015-01-28&rft.volume=21&rft.issue=4&rft.spage=1251&rft.epage=1260&rft.pages=1251-1260&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v21.i4.1251&rft_dat=%3Cproquest_pubme%3E1652430813%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1652430813&rft_id=info:pmid/25632199&rft_cqvip_id=90888889504849534852485053&rfr_iscdi=true